期刊文献+

Endoscopic retrograde cholangiopancreatography guided interventions in the management of pancreatic cancer 被引量:3

下载PDF
导出
摘要 Pancreatic cancer is the leading cause of cancer-related morbidity and mortality with an overall five-year survival of less than 9%in the United States.At presentation,the majority of patients have painless jaundice,pruritis,and malaise,a triad that develops secondary to obstruction,which often occurs late in the course of the disease process.The technical advancements in radiological imaging and endoscopic interventions have played a crucial role in the diagnosis,staging,and management of patients with pancreatic cancer.Endoscopic retrograde cholangiopancreatography(ERCP)-guided diagnosis(with brush cytology,serial pancreatic juice aspiration cytologic examination technique,or biliary biopsy)and therapeutic interventions such as pancreatobiliary decompression,intraductal and relief of gastric outlet obstruction play a pivotal role in the management of advanced pancreatic cancer and are increasingly used due to improved morbidity and complication rates compared to surgical management.In this review,we highlight various ERCP-guided diagnostic and therapeutic interventions for the management of pancreatic cancer.
出处 《World Journal of Gastrointestinal Endoscopy》 CAS 2020年第10期323-340,共18页 世界胃肠内镜杂志(英文版)(电子版)
  • 相关文献

参考文献3

二级参考文献43

  • 1[1]Patel T.Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.Hepatology 2001;33:1353-1357
  • 2[2]Taylor-Robinson SD,Toledano MB,Arora S,Keegan TJ,Hargreaves S,Beck A,Khan SA,Elliott P,Thomas HC.Increase in mortality rates from intrahepatic cholangJocarcinoma in England and Wales 1968-1998.Gut 2001;48:816-820
  • 3[3]Blendis L,Halpern Z.An increasing incidence of cholangiocarcinoma:why? Gastroenterology 2004;127:1008-1009
  • 4[4]Mouzas IA,Dimoulios P,Vlachonikolis IG,Skordilis P,Zoras O,Kouroumalis E.Increasing incidence of cholangiocarcinoma in Crete 1992-2000.Anticancer Res 2002;22:3637-3641
  • 5[5]Bismuth H,Castaing D,Traynor O.Resection or palliation:priority of surgery in the treatment of hilar cancer.World J Surg 1988;12:39-47
  • 6[6]Farley DR,Weaver AL,Nagorney DM."Natural history"of unresected cholangiocarcinoma:patient outcome after noncurative intervention.Mayo Clin Proc 1995;70:425-429
  • 7[7]Weber A,Landrock S,Schneider J,Stangl M,Neu B,Born P,Classen M,Rosch T,Schmid RM,Prinz C.Long-term outcome and prognostic factors of patients with hilar cholanglocarcinoma.World J Gastroentero12007;13:1422-1426
  • 8[8]Gerhardt T,Milz S,Schepke M,Feldmann G,Wolff M,Sauerbruch T,Dumoulin FL.C-reactive protein is a prognostic indicator in patients with perihilar cholanglocarcinoma.World J Gastroentero12006;12:5495-5500
  • 9[9]Khan SA,Thomas HC,Davidson BR,Taylor-Robinson SD.Cholangiocarcinoma.Lancet 2005;366:1303-1314
  • 10[10]Lazaridis KN,Gores GJ.Cholangiocarcinoma.Gastroenterology 2005;128:1655-1667

共引文献32

同被引文献9

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部